申请人:Melinta Therapeutics, Inc.
公开号:US20180066007A1
公开(公告)日:2018-03-08
The present invention provides macrocyclic compounds useful as therapeutic agents of the formula:
or a pharmaceutically acceptable salt, ester, N-oxide, or prodrug thereof, wherein T, R
1
, R
2
, R
3
, D, E, F, and G are as defined herein. More particularly, these compounds are useful as anti-infective, antiproliferative, anti-inflammatory and prokinetic agents.